Utama › Diabetes Jenis 2 › Pennsylvania › Philadelphia
Kajian klinikal Diabetes Jenis 2 di Philadelphia, PA
15 kajian untuk Diabetes Jenis 2 sedang mencari peserta di lokasi dalam dan sekitar Philadelphia (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Mengambil pesertaFasa 2
- Suburban Research Associates, West Chester · 24 mi jauh
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Mengambil pesertaFasa 3
- Thomas Jefferson University, Philadelphia
- Tristar Clinical Investigations PC, Philadelphia
- Suburban Research Associates, West Chester · 24 mi jauh
Phenotyping Genetic Risk for Type 2 Diabetes
Mengambil pesertaSukarelawan sihat dialu-alukan
- Childrens Hospital of Philadelphia, Philadelphia
- University of Pennsylvania, Philadelphia
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Mengambil pesertaFasa 3
- AURORA-2 Clinical Site, Philadelphia
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
Mengambil pesertaFasa 2
- Suburban Research Associates, West Chester · 24 mi jauh
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Mengambil pesertaFasa 3
- Research Site, Philadelphia
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Mengambil pesertaFasa 2
- Suburban Research Associates, West Chester · 24 mi jauh
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
Mengambil pesertaFasa 3
- Children's Hosptl Philadelphia, Philadelphia
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Mengambil pesertaFasa 3
- Children's Hospital of Philadelphia, Philadelphia
- St Christophers Hospital For Children, Philadelphia
The GRoceries Aimed at Increasing Nutrition Study
Mengambil pesertaMenyebut bayaran untuk peserta
- University of Pennsylvania, Philadelphia
CGM for Management of Type 2 Diabetes in Pregnancy
Mengambil peserta
- University of Pennsylvania, Philadelphia
Sleep and Glycemic Control in Type 2 Diabetes Adolescents
Mengambil peserta
- Children's Hospital of Philadelphia, Philadelphia
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
Mengambil pesertaKajian pemerhatian
- Children's Hospital of Philadelphia, Philadelphia
Transformative Research in Diabetic Nephropathy 2.0
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Penn Presbyterian Medical Center, Philadelphia
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
Mengambil peserta
- Thomas Jefferson University, Philadelphia
Kajian Diabetes Jenis 2 di bandar lain
- San Antonio, TX37 kajian
- Houston, TX31 kajian
- Orlando, FL24 kajian
- Boston, MA20 kajian
- Miami, FL19 kajian
- Chicago, IL19 kajian
- Dallas, TX19 kajian
- Columbus, OH18 kajian
- Las Vegas, NV18 kajian
- Atlanta, GA17 kajian
- San Diego, CA17 kajian
- Los Angeles, CA16 kajian
Kajian lain di Philadelphia
- Kanser (semua jenis)59 kajian
- Kanser Payudara56 kajian
- Kanser Paru-paru Bukan Sel Kecil51 kajian
- Kanser Metastatik46 kajian
- Kanser Kolorektal44 kajian
- Kanser Ovari44 kajian
- Kanser Prostat44 kajian
- Kanser Paru-paru36 kajian
- Leukemia Mieloid Akut34 kajian
- Kegagalan Jantung31 kajian
- Kanser Endometrium28 kajian
- Depresi26 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.